These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 16084231

  • 1. Comorbid conditions in the AMICA study patients: effects on the quality of life and drug prescriptions by general practitioners and specialists.
    Caporali R, Cimmino MA, Sarzi-Puttini P, Scarpa R, Parazzini F, Zaninelli A, Ciocci A, Montecucco C.
    Semin Arthritis Rheum; 2005 Aug; 35(1 Suppl 1):31-7. PubMed ID: 16084231
    [Abstract] [Full Text] [Related]

  • 2. Do physicians treat symptomatic osteoarthritis patients properly? Results of the AMICA experience.
    Sarzi-Puttini P, Cimmino MA, Scarpa R, Caporali R, Parazzini F, Zaninelli A, Atzeni F, Marcolongo R.
    Semin Arthritis Rheum; 2005 Aug; 35(1 Suppl 1):38-42. PubMed ID: 16084232
    [Abstract] [Full Text] [Related]

  • 3. Analysis of pharmacologic and nonpharmacologic prescription patterns of general practitioners and specialists in the AMICA study.
    Scarpa R, Sarzi-Puttini P, Cimmino MA, Caporali R, Parazzini F, Zaninelli A, Canesi B.
    Semin Arthritis Rheum; 2005 Aug; 35(1 Suppl 1):24-30. PubMed ID: 16084230
    [Abstract] [Full Text] [Related]

  • 4. Clinical presentation of osteoarthritis in general practice: determinants of pain in Italian patients in the AMICA study.
    Cimmino MA, Sarzi-Puttini P, Scarpa R, Caporali R, Parazzini F, Zaninelli A, Marcolongo R.
    Semin Arthritis Rheum; 2005 Aug; 35(1 Suppl 1):17-23. PubMed ID: 16084229
    [Abstract] [Full Text] [Related]

  • 5. The characteristics of symptomatic osteoarthritis in general and specialist practice in Italy: design and methods of the AMICA Study.
    Parazzini F, Cimmino MA, Sarzi-Puttini P, Scarpa R, Caporali R, Zaninelli A, Ciocci A.
    Semin Arthritis Rheum; 2005 Aug; 35(1 Suppl 1):11-6. PubMed ID: 16084228
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Coxibs: evolution of prescription's behaviour in France.
    Biga J, Gony M, Bourrel R, Souche A, Sommet A, Pathak A, Sciortino V, Taboulet F, Grand A, Lapeyre-Mestre M, Montastruc JL.
    Fundam Clin Pharmacol; 2007 Jun; 21(3):317-25. PubMed ID: 17521301
    [Abstract] [Full Text] [Related]

  • 8. Prescription rheumatology practices among Mexican specialists.
    Goycochea-Robles MV, Arce-Salinas CA, Guzmán-Vázquez S, Cardiel-Ríos MH.
    Arch Med Res; 2007 Apr; 38(3):354-9. PubMed ID: 17350489
    [Abstract] [Full Text] [Related]

  • 9. Predictors of the selection of coxibs over nonselective NSAIDs in an older Medicaid cohort.
    Shireman TI, Rigler SK.
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):210-8. PubMed ID: 17062321
    [Abstract] [Full Text] [Related]

  • 10. An epidemiological study of diagnostic and therapeutic strategies in office practice patients with subacute or chronic pain in the thoracic or low back. Comparison of practices in primary care and rheumatology settings.
    Dreiser RL, Maheu E, Ghozlan R, Rozenberg S, Bourgeois P, Bregeon C, Benhamou CL, Sebert JL, Trèves R.
    Rev Rhum Engl Ed; 1997 Jan; 64(1):26-34. PubMed ID: 9051857
    [Abstract] [Full Text] [Related]

  • 11. Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study.
    Sebaldt RJ, Petrie A, Goldsmith CH, Marentette MA.
    Am J Manag Care; 2004 Nov; 10(11 Pt 1):742-50. PubMed ID: 15623264
    [Abstract] [Full Text] [Related]

  • 12. Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists.
    Greenberg JD, Bingham CO, Abramson SB, Reed G, Sebaldt RJ, Kremer J.
    Arthritis Rheum; 2005 Feb 15; 53(1):12-7. PubMed ID: 15696570
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of training on general practitioners' management of pain in osteoarthritis: a randomized multicenter study.
    Chassany O, Boureau F, Liard F, Bertin P, Serrie A, Ferran P, Keddad K, Jolivet-Landreau I, Marchand S.
    J Rheumatol; 2006 Sep 15; 33(9):1827-34. PubMed ID: 16724375
    [Abstract] [Full Text] [Related]

  • 15. GOAL: multicenter, open-label, post-marketing study of flavocoxid, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin.
    Pillai L, Burnett BP, Levy RM, GOAL Study Cooperative Group.
    Curr Med Res Opin; 2010 May 15; 26(5):1055-63. PubMed ID: 20225990
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association of age with analgesic use for back and joint disorders in outpatient settings.
    Federman AD, Litke A, Morrison RS.
    Am J Geriatr Pharmacother; 2006 Dec 15; 4(4):306-15. PubMed ID: 17296536
    [Abstract] [Full Text] [Related]

  • 18. Problems and needs for improving primary care of osteoarthritis patients: the views of patients, general practitioners and practice nurses.
    Rosemann T, Wensing M, Joest K, Backenstrass M, Mahler C, Szecsenyi J.
    BMC Musculoskelet Disord; 2006 Jun 02; 7():48. PubMed ID: 16749935
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: a randomized, placebo-controlled trial.
    Langford R, McKenna F, Ratcliffe S, Vojtassák J, Richarz U.
    Arthritis Rheum; 2006 Jun 02; 54(6):1829-37. PubMed ID: 16729276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.